Literature DB >> 32386735

Beyond Oligometastases.

David A Palma1, Glenn S Bauman2, George B Rodrigues2.   

Abstract

Year:  2020        PMID： 32386735     DOI： 10.1016/j.ijrobp.2019.12.023

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  7 in total

1.  Reply to: The course of lung oligometastatic colorectal cancer may be a reflection of selection for treatment rather than an effect of stereotactic body radiotherapy.

Authors:  Luca Nicosia; Francesco Cuccia; Filippo Alongi
Journal:  Strahlenther Onkol       Date:  2020-11-26       Impact factor: 3.621

2.  Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy.

Authors:  Glenn S Bauman; Mark T Corkum; Hatim Fakir; Timothy K Nguyen; David A Palma
Journal:  BMC Cancer       Date:  2021-04-14       Impact factor: 4.430

Review 3.  Impact of the extent of lung resection on postoperative outcomes of pulmonary metastasectomy for colorectal cancer metastases: an exploratory systematic review.

Authors:  Elena Prisciandaro; Laurens J Ceulemans; Dirk E Van Raemdonck; Herbert Decaluwé; Paul De Leyn; Luca Bertolaccini
Journal:  J Thorac Dis       Date:  2022-07       Impact factor: 3.005

Review 4.  Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer.

Authors:  Patricia Mae G Santos; Xingzhe Li; Daniel R Gomez
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

Review 5.  Metastasis-directed therapy for oligometastasis and beyond.

Authors:  Thomas H Beckham; T Jonathan Yang; Daniel Gomez; C Jillian Tsai
Journal:  Br J Cancer       Date:  2020-11-18       Impact factor: 7.640

6.  Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 Trial.

Authors:  Mark T Corkum; Hatim Fakir; David A Palma; Timothy Nguyen; Glenn S Bauman
Journal:  Adv Radiat Oncol       Date:  2021-06-05

7.  Cost-Effectiveness Analysis of Local Treatment in Oligometastatic Disease.

Authors:  Dirk Mehrens; Marcus Unterrainer; Stefanie Corradini; Maximilian Niyazi; Farkhad Manapov; C Benedikt Westphalen; Matthias F Froelich; Moritz Wildgruber; Max Seidensticker; Jens Ricke; Johannes Rübenthaler; Wolfgang G Kunz
Journal:  Front Oncol       Date:  2021-06-15       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.